- Active ingredient:
- Gliclazide 30 mg
- Pharmaceutical form:
- MR (modified-release) tablet: White or nearly white, scored, oblong tablets
- Route of administration:
- For oral use. For adults only. The tablet(s) should be swallowed whole without chewing. If a dose is missed, do not increase the dose the next day. As with all hypoglycemic agents, dosage adjustments should be based on the patient’s metabolic response (blood glucose, HbA1c).